Dyne Therapeutics, Inc.
NASDAQ:DYN
29.27 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||
| Net Income
| -235.937 | -168.099 | -149.291 | -59.437 | -14.859 | -4.811 | 76 | -1,240 | 50 | -67 | -356 | 87 | -1,645 | -234 | -1,262 | 174 | 264 |
| Depreciation & Amortization
| 2.461 | 1.683 | 1.088 | 0.7 | 0.271 | 0.024 | 867 | 766 | 614 | 292 | 467 | 26 | 346 | 408 | 359 | 376 | 333 |
| Deferred Income Tax
| -22.97 | 0 | 2.588 | 0.012 | 0 | 0 | 610 | 45 | 477 | 1 | 56 | 0 | 632 | 195 | -436 | 73 | 215 |
| Stock Based Compensation
| 19.972 | 15.178 | 17.542 | 6.591 | 0.026 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 26.307 | -5.379 | 9.256 | 5.112 | 1.405 | 0.601 | -1,596 | 938 | -860 | 1,029 | 268 | 183 | -166 | 488 | -910 | 437 | 522 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | -47 | 42 | -64 | 161 | -75 | -511 | 49 | 16 | 66 | 68 | -114 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 110 | 154 | -119 | -20 | 24 | 1 | -3 | -16 | 7 | 3 | -13 |
| Accounts Payables
| 22.97 | -1.235 | 13.702 | 8.567 | 1.689 | 0.635 | 46 | 84 | 90 | -131 | 71 | -3 | 105 | -18 | -112 | -71 | -15 |
| Other Working Capital
| 3.337 | -4.144 | -4.446 | -3.455 | -0.284 | -0.034 | -1,705 | 658 | -767 | 1,019 | 248 | 696 | -317 | 506 | -871 | 437 | 142 |
| Other Non Cash Items
| 22.009 | 2.972 | -0.746 | 0.514 | 1.323 | 0.021 | 584 | 136 | -215 | -1,336 | -275 | -340 | 813 | -434 | 2,384 | -741 | -471 |
| Operating Cash Flow
| -188.158 | -153.645 | -119.563 | -46.508 | -11.834 | -4.164 | 585 | 676 | 94 | -62 | 175 | -44 | -20 | 423 | 135 | 319 | 341 |
| Investing Activities: | |||||||||||||||||
| Investments In Property Plant And Equipment
| -0.729 | -3.067 | -3.618 | -1.161 | -1.647 | -0.134 | -224 | -326 | -275 | 0 | -98 | 0 | -242 | -333 | 0 | 0 | 0 |
| Acquisitions Net
| 0.023 | 0.034 | 0.008 | 0 | 0 | 0 | -3,319 | 0 | -6,078 | 0 | 234 | 0 | 0 | 0 | 0 | 0 | -128 |
| Purchases Of Investments
| -44.262 | -121.176 | -236.721 | -44.5 | 0 | 0 | 0 | 0 | -250 | 0 | 0 | 0 | 0 | -508 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 128.302 | 211.445 | 102.447 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.023 | -0.034 | -0.008 | -44.5 | 0 | 0 | 784 | -1,821 | 5,409 | -5,148 | 338 | 348 | -12 | 307 | 251 | -102 | -689 |
| Investing Cash Flow
| 83.311 | 87.202 | -137.892 | -45.661 | -1.647 | -0.134 | -2,759 | -2,147 | -1,194 | -5,148 | 474 | 348 | -254 | -534 | 251 | -102 | -817 |
| Financing Activities: | |||||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | -10 | 0 | 0 | -2,589 | -589 | -31 | -14 | -1,917 | -328 | -1,624 | -63 | 0 | 0 | 0 |
| Common Stock Issued
| 54.322 | 36.861 | 157.237 | 246.388 | 19.989 | 0.007 | 0 | 0 | 0 | 719 | 0 | 0 | 3 | -6 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -250 | -1,870 | -843 | -348 | -396 | -291 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 1.953 | 0.529 | 0.584 | 144.302 | 0.02 | 12.415 | 1,312 | 3,353 | 39 | 6,375 | 2,606 | 348 | 2,396 | 291 | -608 | 148 | 433 |
| Financing Cash Flow
| 54.322 | 37.39 | 157.821 | 380.69 | 19.989 | 12.422 | -1,299 | 2,742 | -265 | 5,210 | -154 | -328 | 379 | -69 | -608 | 148 | 433 |
| Other Information: | |||||||||||||||||
| Effect Of Forex Changes On Cash
| 0.004 | 0 | 0 | 0 | 0 | 4.298 | 0 | 0 | 0 | 0 | 0 | -83 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -50.521 | -29.053 | -99.634 | 288.521 | 6.508 | 12.422 | -3,473 | 1,271 | -1,365 | 0 | 495 | -107 | 105 | -180 | -222 | 365 | -43 |
| Cash At End Of Period
| 121.626 | 174.466 | 203.519 | 303.153 | 14.632 | 8.124 | 365 | 1,776 | 505 | 1,870 | 843 | 348 | 396 | 291 | 471 | 693 | 328 |